- Home
- MOGU vs LSTA Comparison
MOGU vs LSTA Comparison
Compare MOGU & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MOGU | LSTA |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.3M | 15.9M |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | MOGU | LSTA |
|---|---|---|
| Price | $1.90 | $1.00 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 20.9K | ★ 78.9K |
| Earning Date | 06-22-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,283,868.00 |
| Revenue This Year | $5,662.49 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.81 | ★ N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $1.27 | $0.96 |
| 52 Week High | $3.11 | $5.07 |
Technical Indicators
Market Signals| Indicator | MOGU | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 38.57 | 34.39 |
| Support Level | $1.27 | $0.99 |
| Resistance Level | $2.10 | $1.28 |
| Average True Range (ATR) | 0.23 | 0.10 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 4.92 | 11.02 |
Price Performance
Historical ComparisonAbout MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.